BioNTech
durable responses in a phase trial in advanced experienced melanoma experienced | BioNTech
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
109 of 156
Related slides by other companies
MAIA Biotechnology
Investor Presentation
July 2023
thio trial patients dosed to date | MAIA Biotechnology
MindMed
Investor Presentation
January 2025
phase efficacy and durability support gad phase trial plans plans | MindMed
Immix Biopharma
Investor Presentation
March 2024
durable responses in amyloidosis clinical trial i a | Immix Biopharma
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Results
March 2022
Investor Day
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights